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The purpose of this study was to determine whether compound zhi zhu xiang (CZZX) exerts anxiolytic-like eﬀects in rats. The
animals were orally administered CZZX (0.75, 1.5, and 3g/kg daily) for 10 days and tested in the elevated plus maze (EPM), Vogel
conﬂict test (VCT), and open ﬁeld. Repeated treatment with CZZX (3g/kg/day, p.o.) signiﬁcantly increased the percentage of
both entries into and time spent on the open arms of the EPM compared with saline controls. In the VCT, repeated treatment with
CZZX(1.5and3g/kg/day,p.o.)signiﬁcantlyincreasedthenumberofpunishedlicks.Thedrugdidnotchangethetotalentriesinto
the open arms of the EPM or interfere with water consumption or nociceptive threshold, discarding potential confounding factors
in the two tests. In the open ﬁeld, locomotion was not reduced, discarding the possible sedative eﬀect of CZZX. In the binding
assay, the binding of [3H] Ro 15-1788 (ﬂumazenil) to the benzodiazepine binding site in washed crude synaptosomal membranes
from rat cerebral cortex was aﬀected by CZZX. These data indicate an anxiolytic-like proﬁle of action for CZZX without sedative
side eﬀects, and this activity may be mediated by benzodiazepine binding site modulation at γ-aminobutyric acid-A receptors.
1.Introduction
Anxiety is a widespread incapacitating psychiatric ailment
that imposes a substantial health burden on society. Ben-
zodiazepines (BZDs) are considered safe drugs and widely
prescribed for their anxiolytic, muscle relaxant, sedative-
hypnotic, and anticonvulsant actions [1]. However, they may
p r o d u c es i d ee ﬀects, such as sedation and myorelaxation,
that are considered unwanted eﬀects of anxiolytic drugs
[2]. Therefore, the search for safe and eﬀective agents has
continued.
Over the past decade, herbal medicines have received
increasing attention from the psychiatry research commu-
nity. This is largely because many herbal preparations have
been found to have beneﬁcial eﬀects for various psychiatric
conditions in experimental animal and clinical studies [3–6].
In Western societies, natural remedies for anxiety disorders,
suchasvalerian(Valeriana oﬃcinalis),St.John’swort(Hyper-
icum perforatum), passion ﬂower (Passiﬂora incarnata), hops
(Humulus lupulus), and kava kava (Piper methysticum),
are readily available [7]. Several herbal mixtures also have
anxiolytic-like eﬀects in rodent models of anxiety (e.g.,
Yokukansan [8] and Xiao-Tan-Jie-Yu-Fang [9]). Moreover,
substantial evidence from our laboratories indicates that
herbal medicines are beneﬁcial in preventing mental illness,
such as vanadium-enriched Cordyceps sinensis [5], gan mai
da zao decoction [10], and Sini tang [6].
Compound zhi zhu xiang (CZZX) originated from
a clinical experimental prescription, and a clinical study
showed that it is an eﬀective and well-tolerated antianxiety
prescription [11]. Among the constituents of CZZX, Vale-
riana jatamansi Jones accounts for the largest proportion
and plays the major therapeutic role. It acts as an “emperor
herb”accordingtotraditionalChinesemedicineformulation
theory. The plant in India is widely known for its use in
the treatment of anxiety, insomnia, epilepsy, failing reﬂexes,
hysteria, neurosis, and sciatica [12]. In some countries, it is
used as an important sedative in herbal medicine. Moreover,
large-scale studies also demonstrated that extracts of Valeri-
ana oﬃcinalis L. s.l. exert anxiolytic eﬀects [13, 14]. Ziziphus
jujubaMill.andAlbiziajulibrissinDurazz.playauxiliaryroles
as“ministerherbs”intheCZZXformulationbecauseoftheir
eﬀects on insomnia. In animal studies, Ziziphus jujuba Mill.
had anxiolytic-like eﬀects at lower doses and sedative eﬀects2 Evidence-Based Complementary and Alternative Medicine
at higher doses in the black and white test and elevated plus
maze [15]. Juncus eﬀusus L. plays an assisting role in CZZX
as an “assistant and messenger herb.” Clinical studies in
Chinarevealedthatitcanregulatediﬀerentmentaldisorders,
such as anxiety, improve sleep, and improve gastrointestinal
function. However, animal studies have not demonstrated
the ability of CZZX to mediate anxiety.
The purpose of the present study was to determine
whether CZZX exerts anxiolytic-like eﬀects in rats. The
animals were tested in the elevated plus maze, Vogel conﬂict
test (VCT), and open ﬁeld. The binding aﬃnity and eﬃcacy
of CZZX at the γ-aminobutyric acid-A- (GABAA-) BZD
receptorweredeterminedtorevealthepotentialmechanisms
that underlie the selective behavioral proﬁle of CZZX.
2.MaterialandMethods
2.1. Animals. Male Sprague-Dawley rats (160–180g) were
obtainedfromtheLaboratoryAnimalCenteroftheAcademy
of Military Medical Sciences and used for this study.
The animals were housed ﬁve per cage under controlled
temperature (22 ± 1◦C) and a 12h/12h light/dark cycle
(lights on at 07:00AM) with free access to food and water.
The experimenter handled the animals daily to acclimate
them to the manipulation. The animals were used only once
and for only one experiment. The experimental procedures
were approved by the Institutional Animal Care and Use
Committee of the Institute of Psychology of the Chinese
Academy of Sciences and in accordance with the National
Institutes of Health Guide for Care and Use of Laboratory
Animals.
2.2. Drugs and Treatment. Four crude drugs (Valeriana jata-
mansi, Ziziphus jujuba, Albizia julibrissin,a n dJuncus eﬀusus)
were purchased from the Medicinal Materials Company of
Hebei Anguo and authenticated by Jin-Li Shi, Department
of Botany, Beijing Chinese Medical University, based on
their micro- and macroscopic characteristics. The quality of
these crude drugs was controlled and processed according
to the Chinese Pharmacopoeia. Drug samples were collected
as voucher specimens and kept with the records. The 35%
ethanolic v/v extract of Valeriana jatamansi (200g/2000mL;
reﬂux, 2h × 3), water extracts of Ziziphus jujuba and Albizia
julibrissin (200g/2000mL; decoction, 3h × 2), and 95%
ethanolic v/v extract of Juncus eﬀusus (20g/300mL; reﬂux,
1h× 2) were ﬁltered and dried under reduced pressure at a
temperature <60◦C. They were then mixed at the ratio stated
in the prescription.
The doses are expressed in terms of the dried weight
of the CZZX extract per unit body weight of the experi-
mental animals (g/kg). Diazepam was chosen as a positive
control drug. For oral (p.o.) administration for 10 days,
CZZX and diazepam were dissolved in saline. Each drug
was administered in a volume of 1mL/100g body weight.
Control animals received vehicle (saline) only. In this study,
the rats were administered CZZX or DZP 60 and 30min
before the test, respectively. The opioid agonist morphine
hydrochloride was obtained from Sigma (St. Louis, MO,
USA). Morphine was administered at a dose of 5mg/kg in a
sterile 0.9% NaCl solution via intraperitoneal (i.p.) injection
30minbeforethenociceptivetest.Alloftheanimaltestswere
performed on the 10th day of treatment.
2.3. Elevated Plus Maze. Anxiolytic activity was measured
using the elevated plus maze [16] .T h em a z ec o n s i s t e do f
two open arms (50.8cm × 10.2cm × 1.3cm) and two closed
arms (50.8cm × 10.2cm × 40.6cm) that extended from a
central platform (10.2cm × 10.2cm).The maze waselevated
to a height of 72.4cm above the ﬂoor. The entire maze was
constructed of clear Plexiglas. On the test days, the animals
were transported to the elevated plus maze room and left
undisturbed in a neutral box for 5min prior to testing.
Immediately after this period, each rat was placed on the
central square facing an open arm and allowed to freely
explore the maze for 5min. Arm entries were deﬁned as the
entry of all four paws into an arm. A computer recorded
the time spent on and number of entries into the open and
closed arms by means of infrared photocells. The percentage
ofopenarmentries(100 ×open/totalentries)wascalculated
for each animal. The apparatus was wiped clean with water
and dried after each subject.
2.4. Vogel Conﬂict Test. The VCT was performed in a
Plexiglas box (29cm × 29cm × 26cm) with a stainless
steel grid ﬂoor. The metallic spout of a drinking bottle that
contained water projected into the box. The simultaneous
contact of the animal with the spout and the grid ﬂoor
closed an electrical circuit controlled by a sensor, producing
seven pulses of water per second whenever the animal was in
contact with both components. Each pulse was considered
a lick. After every 20 licks, the animal received a 0.5mA
footshock for 2s. The sensor recorded the total number of
licks and shocks delivered during the test period. The entire
apparatus was located inside a sound-attenuated cage.
2.5. Water Consumption Evaluation. The apparatus was the
same as the one used in the VCT described above, but the
electric shock-delivering system was rendered inoperative.
2.6. Acute Thermal Pain. A radiant heat apparatus was
used to induce acute pain. The thermal thresholds of the
rats hindpaws were measured. Each rat was placed in a
plastic chamber on a glass ﬂoor, under which a radiant heat
apparatus (100W projector lamp) was located. A beam of
light through a 4mm diameter hole in the apparatus was
focused on the plantar surface of the left hindpaw. The
paw withdrawal latency (PWL) was deﬁned as the time
between the light onset and paw withdrawal and adjusted
to approximately 8s to record the baseline. A cutoﬀ time of
22s was used to avoid tissue damage. Four trials spaced at
least5minapartwereconductedwitheachhindpaw.Thelast
three trials were averaged to provide the mean latency.
2.7. Open Field Test. The open ﬁeld was a 180cm diameter
cylinder with 60cm high walls. The center of the bottom of
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placed into the ﬁeld at the same point against the wall and
allowed to freely explore the apparatus for 10min. The total
path length was recorded by an automatic video tracking
system. Grooming time, the number of rearings, and the
number of defecations were also recorded. After each trial,
the apparatus was wiped clean with a 10% ethanol solution.
2.8. Biochemical Assay
2.8.1. Tissue Preparation. The preparation was performed at
4◦C. The cerebral cortex from four rats was homogenized
f o r5 si n2 0 m Lo f5 0 m MT r i s - c i t r a t e( p H7 . 1 )u s i n ga n
Ultra-Turrax. The suspension was centrifuged at 27,000×g
for 15min, and the pellet was washed three times with
buﬀer. The washed pellet was homogenized in 20mL buﬀer.
The suspension was incubated in a water bath at 37◦Cf o r
30min to remove endogenous GABA and then centrifuged
for 10min at 27,000×g. The ﬁnal pellet was resuspended in
30mL buﬀe ra n ds t o r e di na l i q u o t sa t−20◦C.
2.8.2. [3H] Ro 15-1788 (Flumazenil) Binding Assay. The
binding assay was performed according to a previously
described method [17] with modiﬁcations. The membrane
preparation was thawed and washed with 20mL of 50mM
T r i s - c i t r a t e( p H7 . 1 )a t4 ◦C. The suspension was then
centrifuged at 27,000×gf o r1 0 m i na t4 ◦C. The pellet
was resuspended in 50mM Tris-citrate (pH 7.1) with 2mg
of the original tissue per milliliter of buﬀer and then
used for the binding assay. The membrane suspension
(500μL) was then added to 25μL of test solution (CZZX
extract/standard/blank) and 25μL ﬂumazenil (Ro 15-1788,
78Ci/mmol; Perkin-Elmer Life Sciences), mixed, and incu-
bated for 40min in an ice bath. Nonspeciﬁc binding was
determined using diazepam (1μM, ﬁnal concentration in
assay) added to separate samples. After incubation, 5mL of
ice-cold buﬀer was added to the samples, and the mixture
was poured directly onto Adventic glass ﬁber ﬁlters (GC-50)
under suction and immediately washed with 5mL of ice-
cold buﬀer. The amount of radioactivity was determined by
conventional liquid scintillation counting. Speciﬁc binding
was calculated as total binding minus nonspeciﬁc binding.
All of the experiments were performed in triplicate.
2.9. Statistical Analysis. T h ed a t aa r ee x p r e s s e da sm e a n±
SEM. The data from the elevated plus maze, VCT, acute
thermal pain assessment, and open ﬁeld were analyzed
using one-way analysis of variance (ANOVA) followed by
Dunnett’s test across the ﬁve groups. Probability levels less
than 0.05 were considered statistically signiﬁcant.
3. Results
3.1. Elevated Plus Maze. The one-way ANOVA indicated
signiﬁcant diﬀerences among groups in the time spent in
the open arms of the elevated plus maze (F4,44 = 6.72,
P<0.01; Figure 1(a)) and percentage of open arm entries
(F4,44 = 5.08,P<0.01;Figure 1(b)).CZZXatadoseof3g/kg
produced anxiolytic-like eﬀects, reﬂected by an increase in
the percentage of open arm entries (P<0.05). Doses of 1.5
and 3g/kg also increased the time spent in the open arms
of the maze (P<0.05 and P<0.01, resp.). No diﬀerences
were observed in total arm entries (F4,44 = 0.88, P>0.05;
Figure 1(c)).
3.2. Vogel Conﬂict Test. To conﬁrm the anxiolytic-like eﬀects
of CZZX, we tested an independent group of rats in the
VCT. In this experiment, 50 animals were used. Consistent
with the previous experiment, the one-way ANOVA revealed
signiﬁcant variance among the ﬁve groups (F4,44 = 2.03,
P<0.01). Doses of 1.5 and 3g/kg signiﬁcantly increased
the number of punished licks compared with controls (both
P<0.05; Figure 2).
3.3. Water Consumption. Additional experiments were per-
formed to test whether CZZX increases water consumption
and nociceptive responses, which are potential confounding
factors in the VCT. However, no diﬀerences in the number
of unpunished licks were observed among the ﬁve groups
(F4,45 = 0.35, P>0.05; Figure 3).
3.4. Acute Thermal Pain. We also investigated the eﬀects of
saline, CZZX, and morphine on acute thermal nociceptive
thresholds measured with noxious radiant heat in normal
rats. The one-way ANOVA revealed a signiﬁcant eﬀect of
treatment (F5,54 = 29.67, P<0.05; Figure 4). Morphine
signiﬁcantly increased the PWL compared with the saline
control (P<0.001). In contrast to the analgesic eﬀect
of morphine, CZZX did not have any eﬀect on the PWL
induced by the noxious heat stimulus (P>0.05).
3.5. Open Field Test. No diﬀerence in total path length was
observed among the ﬁve groups (F4,44 = 1.98, P>0.05;
Figure 5), with no diﬀerence in emotional behavior (i.e.,
rearing, grooming, and defecation; data not shown).
3.6. Binding Aﬃnity of CZZX to GABAA-BZD Receptors. In
the GABAA-BZD binding assay, CZZX was able to displace
ﬂumazenil binding. Therefore, it may inhibit the binding of
thespeciﬁcradioligand[3H]Ro15-1788totheBZDreceptor
(Figure 6).
4. Discussion
The present study sought to analyze the behavioral eﬀects of
CZZX,whichisusedtotreat“nervousdiseases”intraditional
Chinese medicine [11]. The results showed that CZZX
exhibited anxiolytic-like activity and did not induce sedative
side eﬀects. The binding assay suggested that the anxiolytic
eﬀects of CZZX may be attributable to the modulation of
GABAA receptors. Altogether, our results lend support to
the traditional use of CZZX in Chinese folk medicine. The
present ﬁndings may also provide important leads for the
development of potent and selective anxiolytic agents.
When the animals were treated with the higher doses of
CZZX (1.5 and 3g/kg) for 10 days, anxiety-like behavior in
the elevated plus maze was signiﬁcantly attenuated, although4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Behavioural performance of rat registered in a 5min session in the elevated plus maze performed 1h after the injection of vehicle
(VEH, p.o.) and CZZX (0.75, 1.5 and 3g/kg, p.o.) or 0.5h after the injection of diazepam (DZP, 1mg/kg, p.o.). (a) Percentage of the number
of entries into the open arm, (b) percentage of time spent into the open arms and (c) total arm entries. Columns represent the means ±
SEM, n = 9-10 rats. ∗P<0.05, ∗∗P<0.01 compared to the control group.
the low dose (0.75g/kg) had no eﬀects on the open-arm
indices, suggesting that CZZX possesses anxiolytic eﬀects in
the elevated plus maze paradigm. Behavior in the elevated
plus maze is related to the natural aversion that rodents
have for elevated and open spaces. Anxiolytic drugs shift the
behavioral response toward exploration of the open arms
[18]. The main potential confounding factors in this model
arechangesinbasallocomotoractivity,whichcanbeinferred
from the total number of entries. CZZX did not alter total
arm exploration in the elevated plus maze, suggesting that
this drug induces speciﬁc anxiolytic-like eﬀects.
Tofurtherstrengthenthesedata,wetestedtheanxiolytic-
like eﬀects of these treatments in the VCT, which involves
the suppression of punished responses. The behavioral
suppression induced by shocks in the VCT is attenuated by
anxiolytic drugs [19–21] .O n ed r a w b a c ko ft h i sp a r a d i g m ,
however, is that drugs that induce antinociceptive eﬀects or
increase water consumption may yield false-positive results.
The doses of 1.5 and 3g/kg CZZX increased the number of
punished licks (i.e.,induced anxiolytic-like eﬀects),butnone
of the doses altered the number of unpunished licks. Thus,
this is unlikely to be a confounding factor in the assessment
of anxiolytic-like eﬀects. Moreover, CZZX was ineﬀective in
the acute thermal pain test, excluding changes in nociceptive
threshold as confounding factors.
The results obtained in the open ﬁeld test showed
that chronic CZZX treatment did not aﬀect the distance
traveled or emotional behavior (i.e., rearing, grooming, and
defecation),suggestingthatthiscompoundmaynotproduce
u n d e s i r a b l es e d a t i v es i d ee ﬀects. These results indicate that
repeated treatment with CZZX may signiﬁcantly improve
anxiety-likebehaviorwithoutproducingsedativesideeﬀects.
Many individual herbal preparations of CZZX and their
major constituents, including Valeriana jatamansi [12],
Ziziphus jujuba [22], Albizia julibrissin [23], and Medulla
junci [24], exert anxiolytic or sedative eﬀects in various
animalmodels.Giventhattheanxiolytic-likeeﬀectsofCZZX
observed in the present study were generated from the eﬀectsEvidence-Based Complementary and Alternative Medicine 5
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Figure 2: Nubmer of punished licks registered in a 5min session
in the vogel conﬂict test performed 1h after the injection of vehicle
(VEH, p.o.) and CZZX (0.75, 1.5 and 3g/kg, p.o.) or 0.5h after the
injection of diazepam (DZP, 1mg/kg, p.o.). Columns represent the
means ± SEM, n = 9-10 rats. ∗P<0.05 compared to the control
group.
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Figure 3: Eﬀects of CZZX on the number of unpunished licks of
rats that had been water-deprived for 48h. Columns represent the
means ± SEM, n = 10 rats.
of individual herbs, one may expect that CZZX has superior
eﬀects in ameliorating anxiety compared with individual
herbal preparations.
In traditional Chinese prescriptions, herbs are usually
mixed before extraction. However, the four herbs contained
in the formula are all sensitive to water temperature. Some
scientiﬁc references and experimental evaluations of the
isolation of the active principles of each plant have been
provided [25], and we extracted the four herbs individually
using diﬀerent solvents and then mixed the extracts accord-
ing to the ratio of crude medicines in the CZZX prescription.
Preliminary pharmacodynamic studies are being performed
in our laboratory to investigate anxiolytic-like eﬀects in
mice. We found that these four herbs that were extracted
individually exhibited higher potency in anxiolytic tests than
the four herbs mixed before extraction (data not shown).
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Figure 4: Eﬀects of CZZX on the nociceptive thermal thresholds.
Columns represent the means ± SEM, n = 10 rats. ∗∗∗P<0.01
compared to the control group.
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Figure 5: Eﬀect of CZZX on the exploratory behavior of rats in the
open ﬁeld test. Columns represent the means ± SEM, n = 10 rats.
∗P<0.05 compared to the control group.
Therefore, these four herbs in the formula were extracted
individually in the present study.
GABAisthemostimportantinhibitoryneurotransmitter
in the human central nervous system. Compelling evidence
suggests an imbalance between excitatory and inhibitory
neurotransmitters in the pathophysiology of convulsions,
anxiety, and sleep [26]. The GABAA receptor system is the
main fast-acting inhibitory neurotransmitter system in the
brain and the pharmacological target for many drugs used
clinically to treat anxiety disorders and epilepsy. GABAA
receptors are heteromeric GABA-gated chloride channels.
The BZD site on GABAA receptors modulates the inhibitory
eﬀects of GABA [27]. Benzodiazepine site agonists, such
as diazepam, increase the GABA-induced chloride chan-
nel opening frequency, exerting anxiolytic, anticonvulsant,
muscle relaxant, sedative-hypnotic, and cognition-impairing6 Evidence-Based Complementary and Alternative Medicine
0 1 2
0
20
40
60
80
100
Log concentration (mg/mL)
−3 −2 −1
S
p
e
c
i
ﬁ
c
 
b
i
n
d
i
n
g
 
(
%
)
Figure 6: Activity of CZZX in the [3H] Ro 15-1788 (ﬂumazenil)
binding assay. Data represent mean ± SEM of four independent
experiments each performed in triplicate.
eﬀects [28] and rendering these agonists the most important
GABAA receptor-modulating drugs in clinical use. For this
reason,discoveringplantsthatenhanceGABAaﬃnityforthe
GABAA receptor is important.
In the present study, diazepam was used as a positive
control. As expected, it increased activity in the open
arms of the elevated plus maze and number of punished
licks in the VCT, conﬁrming its anxiolytic actions. Many
benzodiazepines and related compounds that bind to recep-
tors in the central nervous system have been identiﬁed
in certain plant extracts [29, 30]. In the search for the
underlying mechanism of the anxiolytic-like eﬀect of CZZX,
we performed a complementary assay to investigate whether
the eﬀects of CZZX were attributable to its action at
GABAA receptors. The binding studies were conducted
using the GABA antagonist [3H] Ro 15-1788 (ﬂumazenil).
In the GABAA-BZD binding assay, CZZX displaced [3H]
Ro 15-1788 to brain synaptosomal membranes, indicating
that CZZX had eﬀective concentration-dependent binding
activity and suggesting central BZD-like activity. However,
the EC50 for CZZX was approximately 0.5mg/mL, and
further pharmacokinetic and pharmacodynamic studies are
needed in the future.
Insummary,thepresentstudyshowedthatCZZXelicited
strong eﬀects on anxiety-like behavior, likely mediated by
its BZD-like activity. The extent of anxiolytic activity was
comparable to the eﬀects of diazepam, but CZZX may
be devoid of undesirable side eﬀects, such as sedation.
Therefore, CZZX is a promising candidate for the treatment
of anxiety-like disorders. Studies are being performed in our
laboratories to isolate the active principles of CZZX and
determinethespeciﬁceﬀectsofCZZXonthecentralnervous
system and its underlying mechanism of action.
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